PBAC to reconsider broader vaccine funding after late addition to March agenda

The committee will reconsider whether GSK's meningococcal B vaccine, BEXSERO, should be funded for broader infant and adolescent populations under the National Immunisation Program after the item was added late to the agenda for its March meeting. …